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Early mobilization of critically ill patients with the acute respiratory distress syndrome (ARDS) has emerged as a
therapeutic strategy that improves patient outcomes, such as the duration of mechanical ventilation and
muscle strength. Despite the apparent efficacy of early mobility programs, their use in clinical practice is
limited outside of specialized centers and clinical trials. To evaluate the mechanisms underlying mobility ther-
apy, we exercised acute lung injury (ALI) mice for 2 days after the instillation of lipopolysaccharides into their
lungs. We found that a short duration of moderate intensity exercise in ALI mice attenuated muscle ring finger
1 (MuRF1)–mediated atrophy of the limb and respiratory muscles and improved limb muscle force generation.
Exercise also limited the influx of neutrophils into the alveolar space through modulation of a coordinated sys-
temic neutrophil chemokine response. Granulocyte colony-stimulating factor (G-CSF) concentrations were sys-
temically reduced by exercise in ALI mice, and in vivo blockade of the G-CSF receptor recapitulated the lung
exercise phenotype in ALI mice. Additionally, plasma G-CSF concentrations in humans with acute respiratory
failure (ARF) undergoing early mobility therapy showed greater decrements over time compared to control ARF
patients. Together, these data provide a mechanism whereby early mobility therapy attenuates muscle wasting
and limits ongoing alveolar neutrophilia through modulation of systemic neutrophil chemokines in lung-



















Early mobilization of critically ill patients has emerged as a promising
therapy to improve outcomes of patients with the acute respiratory dis-
tress syndrome (ARDS) and other critical illnesses. Clinical research
studies suggest that early mobilization of critically ill patients improves
a number of meaningful variables, including intensive care unit length
of stay (LOS), hospital LOS, delirium, hospital readmissions, and strength
(1–5). The mechanisms underlying this therapy are currently unknown,
although the improvements in a variety of organ systems (lung, mus-
cle, and brain) suggest that early mobility/exercise may have wide-
spread systemic effects. Despite the apparent efficacy of early mobility
in critically ill patients, routine implementation of these programs
outside the context of clinical trials remains low (6, 7). There are cur-
rently no pharmacologic therapies available to prevent or treat the ex-
tensive muscle wasting and functional disability present in survivors of
critical illnesses, such as sepsis and ARDS (8). It is therefore important
to understand the mechanisms underlying early mobility therapy so
that targets can be identified and therapies can be developed to im-
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www.ScienWe and others have shown that a mouse model of ARDS [referred
to as acute lung injury (ALI) mice] develops profound skeletal muscle
atrophy and weakness, which replicate many of the aspects of muscle
wasting observed in patients with ARDS (1–5, 9, 10). Initiation of
muscle atrophy in this model occurs temporally with lung injury, is
associated with nuclear factor kB (NF-kB) muscle activity, and de-
pends on the expression of the muscle-specific E3 ubiquitin ligase
muscle ring finger 1 (MuRF1) protein, which ubiquitinates contractile
proteins for proteasomal-mediated degradation (6, 7, 9, 10). Although
previous animal studies have shown that preconditioning mice with
exercise can reduce the response to subsequent lung injury (8, 11),
the ability of exercise to therapeutically improve outcomes after lung
injury is unknown.
We exercised ALI mice after lung injury to evaluate the effects of
therapeutic exercise on lung and muscle injury. Exercise led to marked
improvements in lung, limb, and respiratory muscle injury. In this
model, exercise altered expression of a systemic cytokine and chemo-
kine response involving neutrophilic bone marrow mobilization and
recruitment. Therapeutic exercise reduced neutrophil alveolitis, MuRF1-
mediated skeletal muscle atrophy, and muscle weakness. Therapeutic
blockade of granulocyte colony-stimulating factor (G-CSF), a known
biomarker of poor outcomes in patients with ARDS (12), recapitulated
some features of the exercise phenotype in ALI mice. In addition, hu-
man patients with acute respiratory failure (ARF) undergoing early
mobility therapy showed greater decrements in G-CSF levels over
time, compared to non-exercised patients, confirming the relevance of
G-CSF as a mediator of the improved outcomes of mobilized/exercised
critically ill patients. These data in mice and humans suggest a unifying
mechanism underlying the beneficial effects of therapeutic exercise in
mice and humans with lung injury.ceTranslationalMedicine.org 11 March 2015 Vol 7 Issue 278 278ra32 1







ALI mice exhibit marked lung inflammation
Instillation of lipopolysaccharides (LPS) into the lungs of 2-month-old
wild-type (ALI) mice resulted in acute lung inflammation, marked by
predominant alveolar and interstitial cellular infiltration and intersti-
tial thickening at day 3, which was quantified by digital morphometry
software (Fig. 1, A and B). Day 3 bronchoalveolar lavage (BAL) cells
and protein (Fig. 1C) were also similarly increased in ALI mice at this
time point of maximal lung injury, on the basis of our previous work
with this model (10).
ALI mice have reduced physical activity
We have previously shown that ALI mice display profound limb
muscle wasting, mediated in part by the muscle expression of MuRF1
protein, which is up-regulated in the limb muscles of ALI mice during
days 1 to 4 after LPS instillation (10). Here, we observed that ALI mice
exhibited reduced physical activity, quantified by both traveling (Fig. 2A)
and rearing activity (Fig. 2B).
To determine whether muscle wasting in ALI mice phenotypically

























a model of hindlimb immobilization in sham and ALI mice. As previ-
ously reported, one hindlimb is secured in a flexed position so that the
muscles of that limb are completely immobile (13). The contralateral
rear hindlimb serves as an internal control. We applied this hindlimb
immobilization model to sham and ALI mice at day 0 and harvested
the mice at day 3. We found that complete limb immobility increased
MuRF1 mRNA (Fig. 2C) and protein levels (Fig. 2, D and E) in the
tibialis anterior muscle in sham mice as previously reported (13). How-
ever, ALI control conditions were associated with greater MuRF1 levels
compared to sham immobilized conditions. ALI + immobilized mus-
cles failed to display further significant MuRF1 up-regulation, showing
that most MuRF1 activation in ALI mice can be accounted for by ALI
conditions alone and that muscle wasting in ALI mice is phenotypi-
cally different from that induced by immobility. We hypothesized that
this reduction in physical activity was maladaptive and sought to de-
termine whether increased activity/exercise after instillation of LPS
would attenuate the muscle wasting that occurs in ALI mice.
Therapeutic exercise attenuates skeletal muscle atrophy
in ALI mice
We designed exercise regimens that would be expected to approximate
40 to 60% maximal oxygen consumption (VO2 max) in a healthy
young C57BL/6J mouse (14), ranging from 5 min daily to 35 min twice
daily starting 24 hours after the instillation of LPS (day 1). We found
that exercise regimens ranging from 5 min daily to 25 min twice daily
(table S1) attenuated the loss of muscle mass in ALI mice in individual
muscles with a variety of fiber-type compositions. Tibialis anterior
(type IIa/x and type IIb fibers), extensor digitorum longus (type IIax
and type IIb fibers), and soleus (type IIa/x, type IIb, and type I fibers)
muscle mass loss was attenuated at most doses of exercise. At the
highest intensity and duration of exercise, 35 min twice daily, exercise
failed to attenuate the loss of muscle mass in ALI mice (fig. S1A). Fig-
ure 2F demonstrates the ALI and exercise regimen used in the remain-
ing experiments in this article at a dose of 25 min twice daily, hereby
referred to ALI + Ex mice. We found a trend toward improved sur-
vival in ALI + Ex mice using this dose of exercise, but the difference
did not reach statistical significance (97% ALI + Ex versus 90% ALI,
P = 0.06) (fig. S1B).
We further examined the myofiber composition of the soleus and
diaphragm in sham, ALI, and ALI + Ex mice. Similar to our previous
reports, we found that ALI conditions caused type II myofiber atrophy
in the limb muscle (soleus), with relative preservation of type I myofi-
bers. In contrast, ALI mice displayed atrophy of both type I and type II
myofibers of the diaphragm. Exercise in ALI mice attenuated type II
myofiber atrophy in both the soleus and the diaphragm (Fig. 3, A to
C). These data show that therapeutic exercise in ALI mice attenuates
type II myofiber atrophy.
Therapeutic exercise in ALI mice attenuates
MuRF1-mediated atrophy and improves
muscle performance
We have previously shown that up-regulation of MuRF1 protein is
necessary for the skeletal muscle atrophy that occurs in this model
at days 3 to 4 (10, 15). Here, we confirmed that ALI mice had in-
creased MuRF1 mRNA and protein expression compared to sham
mice in all muscles evaluated. Notably, ALI + Ex mice exhibited reduced
MuRF1 mRNA and protein expression in both the limb muscles and




















































n P = 0.01
Fig. 1. Intratracheal instillation of LPS causes lung injury in mice. (A)
Representative hematoxylin and eosin (H&E)–stained left lung sections of
sham and ALI mice are shown and were evaluated for parenchymal inflam-
mation using digital imaging software at low (left panels) or high (middle
and right panels) magnification at day 3. In overlay images, normal alveolar
space (blue), airways (red), bronchial epithelium (yellow), and injured areas
(green) can be identified. Scale bar, 3 mm (left panels); 300 mm (middle and
right panels). (B) Quantification of the percentage of lung inflammation
based on digital morphometry images. (C) Bronchoalveolar total cell counts
(left axis) and protein levels (right axis) in sham and ALI mice on day 3. n =
4 to 6 per group. Data were analyzed using the Student’s two-tailed t test.ceTranslationalMedicine.org 11 March 2015 Vol 7 Issue 278 278ra32 2






























To determine whether therapeutic exercise alters muscle MuRF1
expression in the absence of ALI, we exercised sham mice (Sham +
Ex) with the same exercise protocol used in the ALI + Ex mice.
Exercise alone had no effect on MuRF1 mRNA in the absence of
ALI (Fig. 3D).
We and others have shown that ALI mice have increased muscle
NF-kB activation (9, 10), which is a known upstreammediator of MuRF1
induction (16). Here, we found that ALI + Ex mice had reduced mus-
cle NF-kB activation compared to ALI mice at day 2, measured by
reduced phosphorylation of the NF-kB subunit p65 in nuclear prep-
arations (Fig. 3, G and H).www.ScienceTranslationalMedicine.orgWe have previously shown that ALI
mice develop limb muscle weakness, with
a ~30% decrease in maximal tetanic force
compared to shammice (10). To determine
whether exercise in ALI mice preserves
muscle function, we isolated the soleus
muscle and stimulated the muscle directly
via electrical field stimulation according to
previously published methods (17) adapt-
ed for the soleus muscle. We found a 20
and 14% increase in twitch absolute and
specific forces, respectively, in ALI + Ex
compared to ALI mice (Fig. 3, I and J).
Likewise, absolute and specific tetanic
forces were increased at all measured fre-
quencies in ALI + Ex mice. Maximal te-
tanic absolute and specific forces were
increased 16 and 10%, respectively, in
ALI + Ex versus ALI mice (Fig. 3, K
and L). We found no difference in soleus
muscle fatigability between ALI versus
ALI + Ex mice (fig. S1C). These data
demonstrate that exercise in ALI mice
reduces MuRF1-mediated atrophy and
improves muscle function in ALI mice.
Exercise in ALI mice attenuates
neutrophil alveolitis
Because muscle atrophy and function were
improved in ALI + Ex mice, and mus-
cle atrophy is temporally correlated with
lung injury in this model (10), we quan-
tified lung injury parameters in the three
groups. Surprisingly, we found that ex-
ercise in ALI mice limited the influx of
neutrophils into the alveolar compartment.
BAL total cells were reduced at day 3 in
ALI + Ex compared to ALI mice, with re-
ductions in monocytes/macrophages,
neutrophils, and lymphocytes at this time
point of peak lung inflammation (Fig. 4,
A and B). We also found reduced total
cell counts in the alveolar space of ALI +
Ex mice at most doses of exercise studied
(fig. S1D). Neutrophils are the predom-
inant inflammatory cell in the lung at
day 3 (Fig. 4B), so the reduction in alve-olar cell counts with exercise can primarily be accounted for by re-
duced alveolar neutrophilia. To evaluate the possibility that exercise
increased alveolar neutrophil apoptosis, we labeled BAL neutro-
phils for the apoptosis markers 7-aminoactinomycin D and annexin
V. We found no evidence of increased neutrophil apoptosis in the
alveolar space of ALI + Ex mice (fig. S1E). In contrast to the reduced
cells found in the alveolar compartment, cell-free BAL total protein
or albumin was not reduced in ALI + Ex mice (fig. S1, F and G).
These data suggest that therapeutic exercise in ALI mice reduces






























































































































Fig. 2. Physical activity is reduced in ALI mice. (A and B) Traveling (A) and rearing (B) activity was
measured 2 days before and 3 days after instillation of intratracheal LPS (i.t.LPS). A.U., arbitrary unit. (C
to E) Sham and ALI mice underwent hindlimb immobilization at day 0 and were harvested at day 3.
MuRF1 mRNA (C) and protein (D and E) levels were quantified in the tibialis anterior muscle of sham
and ALI control (C) and immobilized (I) muscles. (F) Experimental scheme of most exercise experiments
detailed within this article. Deviations from this scheme are noted within the text. Values represent means ±
SEM. n = 4 per group (A and B); n =3 to 4 per group (C to E). (A and B) *P = 0.00002, **P = 0.0003, and ***P =
0.00006 with Bonferroni correction at all time points compared to time 0 using the Student’s two-tailed t test.11 March 2015 Vol 7 Issue 278 278ra32 3
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Fig. 3. Therapeutic exercise attenuates ALI-induced muscle atrophy
and improvesmuscle performance. (A) Type I (light) and II (dark)myofibers
and total p65 protein fromgastrocnemius nuclear extracts. D2 (day 2). (I to L)
Ex vivo isolated soleus (I and J) absolute and specific twitch and (K and L)of the soleus and the diaphragm were identified by adenosine triphos-
phatase (ATPase) and laminin (green) staining. Scale bar,100 mm. (B and C)
Muscle fiber cross-sectional area (CSA) was quantified in sham, ALI, and ALI +
Exmice. (D to F)MuRF1mRNA (D) and protein (E and F) levels normalized to
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) in gastrocnemius
(GAS), diaphragm (DIA), and soleus (SOL)muscles. (G andH) Phosphorylatedwww.Scientetanic contractile force measurements. Values represent means ± SEM. All
experimental time points are at day 3, other than (G) and (H), which are at
day 2. n = 4 to 5 per group (A to D); n = 6 to 8 per group of two combined
experiments (F); n = 3 per group (G and H); n = 4 animals and 8 muscles per
group (I to L). Data were analyzed using the Student’s two-tailed t test or
analysis of variance (ANOVA) for group differenceswithmultiple time points.ceTranslationalMedicine.org 11 March 2015 Vol 7 Issue 278 278ra32 4






























Exercise in ALI mice alters the systemic neutrophil
cytokine/chemokine response
We found that exercise (ALI + Ex) reduced total blood leukocytes com-
pared to ALI mice without exercise (Fig. 4C). ALI conditions shifted blood
leukocytes from a predominant lymphocytic (sham mice) to a predom-
inant neutrophilic (ALI mice) profile (Fig. 4D). The reduction in total leu-
kocytes in ALI + Ex mice compared to ALI mice was primarily accounted
for by an about twofold reduction in blood neutrophils (Fig. 4D).
To evaluate for potential systemic mediators underlying the im-
provements in lung and muscle injury seen in ALI + Ex mice, we per-
formed an unbiased inflammatory biomarker array on 144 murine
cytokines in ALI and ALI + Ex mice. Table 1 lists the top up- and
down-regulated proteins with P ≤ 0.08 in the array. We found that
10 proteins were significantly differentially regulated (P ≤ 0.05) in ALI +
Ex versus ALI mice (Table 1). Seven of the 10 significantly differen-
tially regulated proteins (P ≤ 0.05; starred and bolded in Table 1) and
9 of the 15 potentially differentially regulated proteins (P ≤ 0.08;
starred in Table 1) have known roles in neutrophil mobilization and
recruitment. Data from all 144 proteins can be found in table S2. Notably,
therapeutic exercise did not change the levels of tumor necrosis factor–a
(TNF-a), interleukin-6 (IL-6), or IL-10 (table S2), which have been im-
plicated in the protective effect of 5 weeks of prophylactic aerobic exercise
in lung-injured mice (11). These data suggest that therapeutic exercise
in ALI mice has specific immunomodulatory effects, most notably on
regulation of cytokines and chemokines involved in neutrophil mobiliza-
tion and migration. This effect appears mechanistically different from
chronic aerobic “preconditioning” exercise.
Exercise reduces systemic G-CSF concentrations in ALI mice
We chose to focus further investigation on the top down-regulated cy-
tokine in our array, G-CSF, because of its well-describedmechanisms ofwww.ScienceTranslationalMedicine.orgaction (20) and its known relevance in
human ARDS (12, 19). G-CSF protein was
markedly up-regulated (~100-fold) in the
plasma of ALI compared to sham mice.
Exercise profoundly reduced systemic
G-CSF levels in ALI mice (Fig. 5A). We
also quantified IL-17A, IL-17F, and IL-23,
known upstream regulators of G-CSF pro-
duction. We found similar trends in the
pattern of expression of these cytokines,
namely, reduction in systemic levels with
exercise, although only IL-17F reached sta-
tistical significance (Fig. 5, B to D).
Blockade of the G-CSF receptor
in vivo reduces neutrophilic
alveolar influx but does not
prevent muscle atrophy
To determine the specificity of the role of
G-CSF in mediating neutrophilic lung in-
jury and muscle wasting, we systemically
administered G-CSF receptor–blocking
antibodies to ALI mice (ALI + G-CSFR
Ab), starting 24 hours after i.t.LPS, and
harvested the mice at day 3. We found that
G-CSFR blockade reduced cells in the al-
veolar space compared to ALI mice re-ceiving an isotype control antibody (ALI + isotype) to a similar
degree to that seen in ALI + Ex mice (Fig. 5E). In contrast, blockade
of the G-CSFR did not attenuate soleus type II myofiber atrophy as
seen in the ALI + Ex mice (Fig. 5, F and G). Likewise, MuRF1 protein
levels in ALI + G-CSFR Ab–treated mice were not reduced compared
to those in ALI + isotype mice (Fig. 5, H and I) as they were in ALI +
Ex mice. We also administered G-CSFR Ab starting at day −1 or 0
and continued daily through day 2 until harvest at day 3. Similarly,
we found that G-CSFR blockade reduced cellular alveolitis in ALI mice
(fig. S2A) but did not attenuate MuRF1-mediated atrophy (fig. S2, B to D).
These data suggest that G-CSF, potentially driven by IL-17F and/or
IL-23, is a key regulator of the improved alveolar neutrophilic injury
in exercised ALI mice, although the attenuation in MuRF1-mediated
muscle atrophy in ALI + Ex mice occurs through a G-CSF–independent
mechanism.
Therapeutic exercise in humans with ARF is associated
with reduced plasma G-CSF concentrations over time
To confirm the relevance of our murine studies, we obtained banked
plasma from a randomized controlled pilot study of early mobilization
(exercise) versus usual care (no exercise) in patients with ARF in the
Wake Forest Medical Intensive Care Unit. The details of this study
can be found in Supplementary Materials and Methods. Briefly, all pa-
tients randomized to exercise received passive range of motion of the
extremities three times daily, replaced by active physical therapy as
patient interaction improved, which included sitting on the edge of
bed, standing, and walking based on a previously described protocol
(1). The baseline characteristics of patients at enrollment in each arm
can be found in table S3.
Respiratory failure patients randomized to exercise had a 68% re-
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Fig. 4. Therapeutic exercise reduces alveolar neutrophilia. (A and B) BAL total leukocyte (A) and differ-
ential cell counts (B) in sham, ALI, andALI + Exmice at specified time points. (C andD) Total blood leukocytes
(C) and differential cell counts (D) were measured in sham, ALI, and ALI + Ex mice at day 3. n = 3 to 6 per
group. Data were analyzed using the Student’s two-tailed t test.11 March 2015 Vol 7 Issue 278 278ra32 5





























in control patients over this time interval (Fig. 6A). Despite randomi-
zation, baseline (day 1) levels of G-CSF were higher in the exercise
group. We therefore normalized the data to adjust to the mean base-
line level of G-CSF for each group (Fig. 6B). After this adjustment, we
found that G-CSF was significantly reduced at the day 5 (P = 0.0538)
and day 7 (P = 0.0072) time points in the exercise versus no exercise
groups. These data add human relevance to the murine findings de-
scribed above, which show that therapeutic exercise reduces systemic
levels of G-CSF in ALI mice.D
o
DISCUSSION
In these studies, we have identified mechanisms underlying the ben-
efits of early mobility therapy demonstrated by previous clinical inves-
tigations (1, 2, 4, 5). We find that therapeutically treating ALI mice
with moderate intensity exercise of 2 days’ duration improved both
skeletal muscle wasting and neutrophilic alveolar influx. Exercise
appears to have specific immunomodulatory effects, most notably
on limiting the mobilization and recruitment of neutrophils from
the bone marrow to the lung by neutrophil cytokines and chemokines.
G-CSF appears to be a key mediator of this process and is reduced in
humans and mice with lung injury undergoing therapeutic exercise.
The attenuation in muscle atrophy with exercise in ALI mice occurs
independently of G-CSF, because inhibition of the G-CSFR did not
improve muscle atrophy in ALI mice.
Our data support the concept that although neutrophils are critical
for the early response to inflammation or infection in the lung, ongoingwww.Scienlung neutrophilia promotes lung injury (21). In mouse models of lung
injury induced by endotoxin (22) or endotoxin plus oxygen (23), neu-
trophil depletion is protective. In addition, prolonged alveolar neutro-
philia is associated with mortality in patients with ARDS (18, 19, 24).
Our data suggest that therapeutic exercise in mice and humans may
act as a rheostat to dampen ongoing neutrophil numbers by reducing
G-CSF, which may, in turn, be driven by down-regulation of IL-17F
and IL-23 (25). G-CSF’s activity in this model is likely occurring through
binding to the G-CSFR, which is present on neutrophils, monocytes,
and bone marrow hematopoietic stem/progenitor cells (26), as well as
myoblasts (27) and endothelial cells (28).
The administration of recombinant G-CSF (rG-CSF) can cause
lung injury in rats (29, 30) and has been associated with ARDS in im-
munocompromised patients (31, 32), although systemic administra-
tion of rG-CSF in nonimmunocompromised patients with pneumonia
does not appear to lead to an increase in ARDS (33–35). Suratt et al.
demonstrated in a large cohort of ARDS patients that endogenous
G-CSF levels are positively correlated with duration of mechanical
ventilation, organ failure, and mortality (12). Our results in mice sug-
gest that the endogenous G-CSF contributes to alveolar neutrophilic
injury and that therapeutic exercise helps reduce G-CSF over time. Col-
lectively, these data suggest that G-CSF is at least a biomarker and may
be pathogenic in ARDS. In contrast to this, the lack of ARDS develop-
ment with rG-CSF administration in pneumonia patients suggests that
rG-CSF alone is not sufficient to cause/promote ARDS.
The actions of G-CSF in skeletal muscle have also previously been
examined. Hara et al. have shown that the G-CSFR is transiently
expressed in cardiotoxin-injured regenerating mouse skeletal muscle:
blockade of the G-CSFR is deleterious for muscle regeneration in this
model, suggesting that G-CSF is beneficial for repair after muscle in-
jury (27). Although we found no harm to the skeletal muscle after
blocking the G-CSFR in our model, this issue and its potential nega-
tive implications for muscle regeneration after injury will need to be
considered.
In addition to the well-described role of G-CSF in neutrophil mo-
bilization and activation (36), 9 of the 15 proteins in our array with P <
0.08, including CXCL15 (lungkine) (37), keratinocyte chemoattractant
(KC) (23), growtharrest specific6 (GAS6) (38), IL-17F/B (39),CXCL10(40),
galectin-1 (41), and macrophage inflammatory protein–2 (MIP-2)
(23), have been implicated in neutrophil migration. Because these
chemokines alter neutrophil migration, our data suggest that exercise
induces a coordinated response that reprograms bone marrow mobili-
zation, activation, and migration of neutrophils. Further studies are
needed to define the roles of each of these cytokines/chemokines in this
model, as well as the other proteins that are differentially regulated in
ALI + Ex mice.
Previous work has demonstrated that 4 to 8 weeks of prophylactic
exercise reduce lung injury in mouse models of asthma (42, 43) or ALI
(11). Gonçalves et al. showed that 4 to 6 weeks of prophylactic aerobic
exercise reduced lung neutrophilia and TNF-a and increased IL-6 and
IL-10 after LPS injury (11). We found no change in TNF-a, IL-6, or
IL-10 with 2 days of therapeutic exercise after lung injury. This sug-
gests that preconditioning and therapeutic exercise both benefit the
lung response to LPS-induced injury, although the mechanisms me-
diating these benefits may differ.
Our study also has implications for the timing and delivery of early
mobility therapies in humans with ARDS. Because exercise in our lung-
injured mice affected cytokines involved in neutrophil mobilizationTable 1. Exercise in ALI mice induces a systemic neutrophil cytokine/
chemokine response. An unbiased inflammatory biomarker array of 144
proteins was performed on the plasma of ALI + Ex and ALI mice at day 3.
n = 4 per group. Displayed are the proteins with P values ≤0.08 in the ALI +
Ex versus ALI mice. Proteins in bold have P values ≤0.05. All proteins can be
found in table S2. Starred cytokines (*) have been previously implicated in
neutrophil mobilization, activation, and/or migration.Response to exercise Protein Fold change % Change PDown-regulation G-CSF* −2.6 −160 0.02CXCL15* −2.4 −140 0.02KC* −2.0 −100 0.08Osteoprotegerin −1.9 −90 0.03GAS 6* −1.7 −70 0.04IL-17F* −1.6 −60 0.05VEGFR3 −1.4 −40 0.02IL-17B* −1.2 −20 0.02DKK-1 −1.2 −20 0.06IL-1ra −1.5 −50 0.06CXCL10* −1.5 −50 0.06HGF −1.3 −30 0.07Up-regulation Galectin-1* 2.1 +110 0.009MMP-3 2.0 +100 0.03MIP-2* 1.3 +30 0.02ceTranslationalMedicine.org 11 March 2015 Vol 7 Issue 278 278ra32 6






























and migration, and neutrophil influx into the alveolar space is an early
event during the time course of ARDS, our findings imply that early
mobility therapies in the critically ill should start as early as possible.
We also found that the highest intensity of exercise in ALI mice didwww.ScienceTranslationalMedicine.orgnot attenuate muscle wasting. Intense ex-
ercise in physically fit humans has been as-
sociated with leukopenia and an increased
risk of upper respiratory tract infections
after training (44). Exercise doses ranging
from 5 to 25 min twice daily generally at-
tenuated the loss of muscle mass in ALImice;
conversely, the highest exercise dose 35 min
twice daily either increased or failed to at-
tenuate (depending on the muscle studied)
muscle wasting. This response to exercise,
in which low to moderate exercise is pro-
tective but the highest intensity exercise is
detrimental, fits with the previously pro-
posed “J-curve” immune response to exercise
observed in humans (45). Future clinical
studies should focus on exercise intensity
dosing strategies in ARDS patients.
We have previously shown that muscle
wasting in ALI mice is associated with
increased activity of muscle NF-kB (10),
a known promoter of muscle atrophy and
upstream mediator of MuRF1 expression
(16). Others have shown that exercise can
reduce NF-kB lung activation in injured
mouse lungs (42), and we also find that
therapeutic exercise acutely reduces muscle
NF-kB activation, which may drive the
down-regulation of MuRF1 expression in
ALI + Ex mice. Previous investigators have
shown that the NF-kB–mediated effect of
exercise occurs through a glucocorticoid
receptor–dependent mechanism (46).
Last, and in line with our previous
studies, ALI mice developed type II myo-fiber atrophy after lung injury. We found both type I and type II myo-
fibers in the diaphragm atrophy in ALI mice, consistent with a recent
report of diaphragmatic biopsies in critically ill humans (47). Thera-
peutic exercise in ALI mice attenuated type II myofiber atrophy in the
limb muscle and diaphragm but did not improve type I myofiber at-
rophy in the diaphragm. Because MuRF1 is preferentially expressed in
type II myofibers (48), we hypothesize that this is the reason for the
discrepancy, in that exercise reduces whole-muscle MuRF1 expression
in both the limb and the diaphragm but does not attenuate the type I
myofiber atrophy in the diaphragm. It is also noteworthy that exercise
also had beneficial effects on limb muscle function that were
independent of muscle atrophy, given that most improvement in force
production in the soleus was from specific, not absolute, force in ALI +
Ex mice.
There are limitations to our study. We have not examined neutrophil
function in ALI + Ex mice. The coordinated neutrophil cytokine mod-
ulation seen with exercise would suggest changes in neutrophil func-
tionality, including possibly their ability to migrate across endothelial/
epithelial barriers. The roles of other differentially regulated cyto-
kines besides G-CSF in ALI + Ex mice were not examined in this
study. Future work should examine the role of therapeutic exercise in
mice with sepsis, such as the cecal ligation and puncture model. Ad-
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Fig. 6. Early mobility therapy reduces plasma G-CSF over time in pa-
tients with ARF. (A) G-CSF concentrations measured by enzyme-linked im-
munosorbent assay (ELISA) at specified time points on plasma samples
from patients in a randomized controlled study of early mobility therapy.
(B) G-CSF concentrations normalized to the mean baseline concentration
of G-CSF of each group at specific time points. Group differences over time
were analyzed using the generalized estimating equation (GEE) method,
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Fig. 5. Blockade of G-CSF activity limits lung injury but does not atten-
uate muscle atrophy. (A to D) G-CSF, IL-17A, IL-17F, and IL-23 protein quan-
tification in the plasma of sham, ALI, and ALI + Ex mice. (E) BAL cell counts
were quantified at day 3 after systemic administration of isotype antibody
(ALI + isotype Ab), exercise (ALI + Ex + vehicle), or G-CSFR–blocking antibody (ALI + G-CSFR Ab) 1 day after
i.t.LPS administration. (F) Type I (light) and II (dark)myofibers of the soleus were identified by ATPase and
laminin (green) staining. (G) Cross-sectional area was quantified in ALI + isotype Ab, ALI + Ex + vehicle, and
ALI + G-CSFR Ab mice. Scale bar,100 mm. (H and I) Soleus muscle lysates were probed for MuRF1 protein
and normalized to GAPDH in sham, ALI + isotype Ab, ALI + Ex + vehicle, and ALI + G-CSFR Ab mice (H) and
quantified by densitometry (I). n = 3 to 7 per group. Data were analyzed using the Student’s two-tailed t test.11 March 2015 Vol 7 Issue 278 278ra32 7
R E S EARCH ART I C L Epatients need to be confirmed in a larger cohort of patients. Future
studies are needed to clarify these issues, as well as the mechanism re-
sponsible for decreasing G-CSF during exercise.
In summary, therapeutic exercise improves both neutrophilic alve-
olar lung injury and skeletal muscle wasting in an animal model of
ARDS. A short duration of acute exercise in ALI mice reduces neu-
trophil mobilization and recruitment to the lung and attenuates MuRF1-
mediated skeletal atrophy and the loss of specific force. Pharmacologic
blockade of neutrophil mobilization and recruitment via G-CSF and
other neutrophil chemokines are attractive targets to facilitate resolu-
tion of lung injury but may not attenuate the skeletal muscle wasting
associated with ARDS. Early mobilization of patients with lung injury
is a promising therapy to improve the outcomes of patients with ARDS.
Additional studies are needed to further elucidate the mechanisms
































The aim of this study was to uncover mechanisms underlying the clin-
ical benefits of early mobility therapy documented in various clinical
studies. The study was performed using both a murine lung injury
model and plasma from lung-injured humans undergoing early mo-
bility therapy. The mouse studies were carried out by instillation of
LPS into the lungs of mice. Subsets of mice underwent limb immo-
bilization or performed therapeutic exercise after lung injury using a
treadmill. Mice were randomly assigned to treatment groups, and
where possible, the researchers were blinded to the treatment groups
until statistical analysis. The predefined study endpoints included var-
ious aspects of muscle function and size, including maximal tetanic
force, myofiber cross-sectional area, and quantification of muscle-
wasting genes and proteins. Lung injury was quantified by alveolar cell
counts and protein and histology scores. Systemic mediators of ther-
apeutic exercise were quantified in mouse plasma with an inflamma-
tory biomarker array. Quantification of lung andmuscle injury parameters
was performed with the following techniques: immunostaining, Western
blotting, flow cytometry, ex vivo muscle stimulation, ELISA, and reverse
transcription quantitative polymerase chain reaction (RT-qPCR).
The human mobility study was approved by the Wake Forest Hu-
man Subjects Committee and the Institutional Review Board and con-
ducted from July 2007 to July 2009. Plasma was obtained from 93
patients randomized to receive early mobility (exercise) or usual care
(no exercise). After performing our murine studies in 2013, we ana-
lyzed the banked plasma collected during the human study for quan-
tification of G-CSF.
ALI animal model
All procedures were approved by the Institutional Animal Care and
Use Committee of Wake Forest School of Medicine. Eight- to 12-week-
old male wild-type C57BL/6 mice (The Jackson Laboratory) were anes-
thetized with an intraperitoneal injection of ketamine (150 mg/kg)
and acetylpromazine (13.5 mg/kg), and the trachea was exposed.
Escherichia coli LPS (O55:B5 L2880, lot 111M4035V, Sigma-Aldrich)
(ARDS mice) at 3 mg/g mouse or an equivalent volume of sterile water
(sham mice) was instilled intratracheally using a 20-gauge catheter as
previously described (10).www.ScienHindlimb immobilization model
A recently described hindlimb immobilization model using a surgical
staple was applied as previously described (13). Sham and ALI mice
underwent hindlimb immobilization at the time of i.t.LPS or i.t.H2O
conditions by applying a surgical staple to the distal hindlimb in the
normal flexion position. The contralateral hindlimb served as a control.
Mouse treadmill
Mice exercised on a six-lane mouse treadmill (Columbus Instruments)
at 0° incline at varying intensities and durations, using a graded pro-
tocol with durations ranging from 5min once daily to 35 min twice daily.
Exercise regimens began 24 hours after i.t.LPS instillation (day 1) and
continued through day 2. Animals were sacrificed on day 3, 12 hours
after the final treadmill exercise. Speed was increased every 5 min.
Maximal tolerated speed or duration was defined as the lack of wil-
lingness to run on the treadmill for more than 2 s despite a 2-mA
shock. See table S1 for the dose and duration of each exercise group.
In vivo G-CSFR inhibition
A neutralizing antibody to the G-CSF receptor (G-CSFR/CD114 Ab,
MAB6039, R&D Systems) or isotype control (MAB0061, R&D
Systems) was administered to ALI mice at 0.5 mg per mouse per
day on days 1 and 2 after the administration of i.t.LPS (at day 0).
The dose was based on a previous publication (27). For G-CSFR Ab
prophylaxis experiments, G-CSFR Ab was administered at day −1 or 0
and continued daily through day 2 until harvest at day 3.
Other experiments
Details of activity and lung injury measurements, muscle contractile
and histology assessments, Western blotting, biomarker arrays, ELISAs,
RT-qPCR, and the human mobility study can be found in Supplemen-
tary Materials and Methods.
Statistics
Data are presented as means ± SEM. Data from each experiment were
confirmed by two or more replicative experiments. The data presented
are from representative or combined experiments where indicated.
Differences between two groups were compared with the Student’s t
test or the Mann-Whitney test for nonparametric data. Pairwise com-
parisons were performed using the Student’s t test. Survival was ana-
lyzed using the log-rank (Mantel-Cox) test. These data were analyzed
with GraphPad Prism 6.0e (GraphPad Software). Inflammatory bio-
marker array data were analyzed using t test statistics to get P values
for each protein, which are reported as uncorrected values without
correction for multiplicity testing. The fold change for each protein
was the ratio of the averaged intensities of the two groups. The human
G-CSF data differences between groups over time were compared
using the GEE implemented in R package GEEPACK (49), where
the regression model included the interaction between treatment and
time, and we used an unstructured working matrix. Human G-CSF data
were normalized by adjusting all the data with the averaged value for
each group at time zero. All raw data can be found in table S4.SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/7/278/278ra32/DC1
Materials and MethodsceTranslationalMedicine.org 11 March 2015 Vol 7 Issue 278 278ra32 8
R E S EARCH ART I C L EFig. S1. Supplemental lung and muscle data from ALI and ALI + Ex mice.
Fig. S2. Prophylactic blockade of the G-CSFR in ALI mice.
Table S1. Exercise protocols in lung-injured mice.
Table S2. Inflammatory biomarker array for ALI + Ex versus ALI mice.
Table S3. Patient characteristics at enrollment of randomized pilot study of early mobility in
patients with ARF.
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mechanisms, suggesting potential future approaches for more directed therapeutic intervention.
decreased lung inflammation. Although these improvements are both linked to exercise, they occur by different
therapeutic exercise. The benefits of exercise in this setting include attenuation of muscle wasting as well as 
respiratory distress syndrome, which they also confirm in human patients with respiratory failure who receive
these observations by using mouse models to find a mechanistic link between exercise and benefits in the acute 
 help explainet al.have its place even among the sickest patients in the intensive care unit. New findings by Files 
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